Good MorningMarkets were mixed on Wednesday, moving first lower on fears of inflation and then higher after the FOMC minutes showed the committee ready to raise interest rates and begin shrinking its balance soon. What the minutes did not show was the possibility of two 25 basis point hikes at the March meeting as the most recent data has suggested. While the market reacted favorably to the news, traders and investors are warned not to read too much into the minutes or the market's reaction because the stock market correction is not yet over.
In other news, the Retail Sales figures for January were much better than expected and show sales up more than 3.0% over last year. The takeaway, however, is that consumer-level inflation is running at a near 10% pace YOY which means the gains in sales are nothing more than price increases. The good news is that inflation is expected to tame in the second half and that should take some of the pressure off of the consumer. Featured: SAGA Metals nears a key milestone in critical minerals race (Ad) 
|
Markets | | Shares of social media titan Twitter (NYSE: TWTR) are up more than 12% since the end of last month, and have had more green days in the three weeks since than their stock has had since last summer. That was shortly after shares hit an all time high and investors were expecting them to crack on with ... Read the Full Story |
|
From Our Partners | | Barrick Mining has spent decades building one of Nevada's richest gold districts, anchored by Fourmile, Goldrush, and Cortez Hills, deposits that could hold up to 60 million ounces of gold.
One overlooked explorer controls 142 claims bordering Fourmile and sitting less than a mile from Goldrush. New geological modeling aims to reveal what's beneath this largely untested ground, while a planned 5% royalty spin-off could give shareholders a separate stake in the project. | | Read the full report before the next catalyst hits |
|
Markets | |
Experience management system provider Qualtrics International (NYSE: XM) stock has bounced after bottoming at the $21.72 level. The Company was spun-off from SAP (NYSE: SAP) several years ago and is coming into its own. While it is yet to turn profitable, it has provided forecast to reach breakeve... Read the Full Story |
|
Industrials | |
Institutions Put A Bottom In SiteOne Landscape Supply
The insiders have been selling their shares of SiteOne Landscape Supply (NYSE: SITE) for the last year, but it doesn’t matter. The insider sales are small, regular, and related to share-based compensation so not a worry. The insiders st... Read the Full Story |
|
From Our Partners | | Trader Chris Pulver says a new SEC document dropping the day-trading limit to $2,000 has created the biggest retail opportunity he has seen in over 30 years.
His strategy targets what he calls Flashpoints - moments when market makers must move billions of dollars on the S-P 500 in a narrow window. Research shows one recent signal would have returned 83.7% in 36 minutes and another 62.8% in 51 minutes.
Lance Ippolito flew to Utah for a full breakdown of the method. | | Tap here to see the complete Flashpoint trading breakdown now |
|
Markets | |
The architect of digital structures continues to face obstacles in the real world but may still be a long-term play
Billions of dollars are already being committed to building the metaverse. And, by the amount of hype being generated, that’s likely to be only a down payment. That’s cr... Read the Full Story |
|
Communication Services | |
Metaverse Stock Roblox At Rock Bottom Prices
Roblox (NYSE: RBLX) came on to the scene with a fanfare of expectations that are still in the picture but more elusive than the market first priced in. Those expectations, and the subsequent dose of reality, sent shares first to the moon and then to t... Read the Full Story |
|
From Our Partners | | Lance Ippolito spent nearly two decades trading the markets, appearing on MoneyShow, Cheddar TV, CNN Money, and MarketBeat.
His free guide, Options Trading Explained, covers two tickers pros call their secret weapon, Wall Street's daily hidden edge, and a strategy that targets payouts around 4 PM ET.
It also explains how to avoid overnight risk when trading options. | | Download your free options trading guide now |
|
Consumer Discretionary | |
There’s A Short-Squeeze In Haverty Furniture Company Waiting To Happen
Those who’ve been reading Marketbeat.com for a while will know that we are fond of the U.S. furniture industry including Haverty Furniture Company (NYSE: HVT). Suffice it to say that these are, generally speaking,... Read the Full Story |
|
Consumer Discretionary | |
Domestic casino operator Penn National Gaming, Inc. (NASDAQ: PENN) stock made a spectacular rise from pandemic lows of $3.75 in March 2020 soaring to a high of $142 a year later only to collapsed to a low of $37.76 in January 2022. The Company continues to grow its Barstool Sportsbook brand and ad... Read the Full Story |
|
Industrials | |
In the early 2000s, Virgin Galactic began the journey to open up space to paying customers. Finally, in July 2021, Branson and three crew members traveled to Spaceport America, Virgin Galactic’s human spaceflight headquarters in southern New Mexico on the VSS Unity.
In the same month, Jeff... Read the Full Story |
|
Materials | |
Highly-Valued Ecolab Hit By Inflation
Shares of Ecolab (NYSE: ECL) look like they are on a bottom but we aren’t so sure this bottom is going to last. We had our reservations even before the company released Q4 earnings and it had nothing to do with the results or the report. The stock is t... Read the Full Story |
|
Materials | |
Huntsman Breaks Out To New Highs
Huntsman (NYSE: HUN) is a diversified organic chemicals company with customers in end markets ranging across all verticals and industries. The company has been working hard over the past year or so to reposition itself as a more focused company and those efforts ... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day BioVie Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of chronic debilitating conditions in the United States. Its products pipeline includes BIV201, which completed Phase IIa clinical trial for the treatment of ascites caused due to chronic liver cirrhosis; and NE3107, a potentially selective inhibitor of inflammatory extracellular single-regulated kinase, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease, as well as Phase 2 clinical trial for the treatment of Parkinson's disease. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada. | | View Today's Stock Pick |
|
